Less Ads, More Data, More Tools Register for FREE

Pin to quick pickspolarean Regulatory News (POLX)

  • There is currently no data for POLX

Holding(s) in Company

19 Jun 2024 17:23

RNS Number : 1203T
Polarean Imaging PLC
19 June 2024
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BF3DT583

Issuer Name

POLAREAN IMAGING PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Rathbones Investment Management Ltd

City of registered office (if applicable)

London

Country of registered office (if applicable)

United Kingdom

Name

City of registered office

Country of registered office

Investec Wealth & Investment Limited

London

United Kingdom

4. Details of the shareholder

Name

City of registered office

Country of registered office

Hero Nominees Limited

St Peter Port

Guernsey

Ferlim Nominees Limited

London

United Kingdom

Rathbone Nominees Limited

London

United Kingdom

5. Date on which the threshold was crossed or reached

17-Jun-2024

6. Date on which Issuer notified

19-Jun-2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

15.140900

0.000000

15.140900

60163200

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BF3DT583

60163200

15.140900

Sub Total 8.A

60163200

15.140900%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Rathbones Group PLC

Rathbones Investment Management Limited

15.099900

15.099900%

Rathbones Group PLC

Investec Wealth & Investment Limited

0.041100

0.041100%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

None

12. Date of Completion

19-Jun-2024

13. Place Of Completion

Port of Liverpool Building, Liverpool L3 1NW

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUKUNRSRUNAAR
Date   Source Headline
23rd Dec 20257:00 amRNSCancellation - Polarean Imaging Plc
15th Dec 20254:03 pmRNSResult of General Meeting
1st Dec 20257:00 amRNSChest coil passes Philips compatibility testing
25th Nov 20257:00 amRNSFirst Xenon Hyperpolariser in Asia
24th Nov 20257:00 amRNSKorean distributor agreement with DK Healthcare
14th Nov 20257:00 amRNSProposed Cancellation of Admission & Notice of GM
27th Oct 20253:37 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSStrategic review and consideration of AIM listing
6th Oct 20257:00 amRNSAscend Imaging agreement expansion
29th Sep 20257:00 amRNSUniversity of Virginia Health Hospital agreement
25th Sep 202512:14 pmRNSNational Institutes of Health system order
25th Sep 20257:00 amRNSHalf-year Report
16th Sep 20257:00 amRNSNotice of Results
11th Sep 20254:36 pmRNSHolding(s) in Company
12th Aug 20257:00 amRNSSubmission of new Phase III study protocol to FDA
24th Jul 20257:00 amRNSBlock Listing Six Monthly Return
24th Jun 20257:00 amRNSPromotion & sales representative agreement
9th Jun 20254:16 pmRNSResult of AGM
2nd Jun 20257:00 amRNSFDA expands XENOVIEW indication
21st May 20257:00 amRNSDr. Bastiaan Driehuys awarded by ATS
15th May 202512:48 pmRNSXenon MRI featured prominently at ATS 2025
14th May 20252:25 pmRNSOngoing collaboration with Philips
8th May 20257:00 amRNSFinal Results
6th May 20252:59 pmRNSHolding(s) in Company
25th Apr 20257:00 amRNSNotice of Results
10th Mar 20257:00 amRNSExpansion of Xenon MRI imaging platform
27th Feb 20257:00 amRNSFY24 trading update
19th Feb 20257:00 amRNSVirtual Investor Day
3rd Feb 20257:00 amRNSTaiwanese distributor agreement with Sumtage
30th Jan 20257:00 amRNSKey patent in China secured
28th Jan 20257:00 amRNSCollaboration to Advance Lung Imaging Innovation
24th Jan 20257:00 amRNSBlock Listing Six Monthly Return
11th Dec 20242:52 pmRNSHolding(s) in Company
21st Nov 20247:00 amRNSFDA clears Chest Coil in GE HealthCare MRI Systems
25th Sep 20247:00 amRNSVirtual investor day
4th Sep 20247:00 amRNSHalf-year Report
3rd Sep 20247:00 amRNSAppointment of Vice President of Sales
28th Aug 20247:00 amRNSAppointment of Chief Medical Advisor
21st Aug 20247:00 amRNSNotice of Results
15th Aug 20247:00 amRNSAppointment of Bastiaan Driehuys as consultant
1st Aug 20247:00 amRNSFDA submission to expand minimum age for XENOVIEW™
31st Jul 20247:00 amRNSNew Xenon MRI System trade-in agreement
29th Jul 20247:00 amRNSRepricing of Options and Grant of Options
26th Jul 20247:00 amRNSBlock Listing Six Monthly Return
24th Jul 20242:36 pmRNSResult of AGM
19th Jul 202410:36 amRNSXenon MRI System trade-in agreement
18th Jul 20245:33 pmRNSPDMR Dealing
28th Jun 20247:00 amRNSFinal Results
19th Jun 20245:23 pmRNSHolding(s) in Company
19th Jun 20245:23 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.